Next Quarterly Earnings
After-hours — typically from around 10:00 p.m. German time (after the US close at 4:00 p.m. New York time).
Medpace Holding is a leading global Contract Research Organization (CRO) providing comprehensive clinical development services. The company supports biopharmaceutical and medical device companies in drug development, from clinical trials to regulatory approval. With scientific expertise, Medpace drives innovation within the pharmaceutical and biotechnology industries.
After-hours — typically from around 10:00 p.m. German time (after the US close at 4:00 p.m. New York time).
Medpace Holding is scheduled to report its next quarterly earnings on 10/26/2026. After-hours — typically from around 10:00 p.m. German time (after the US close at 4:00 p.m. New York time).
Medpace Holding last reported quarterly earnings on 7/22/2026 (Q2 2026). Earnings per share (EPS) came in at 4.25 USD.
Across its last 4 earnings reports, Medpace Holding stock moved by ±13.8% on average the following day. The largest reaction was -22.6% on 04/22/2026; 1 of 4 reactions were positive.
Medpace Holding has beaten analyst EPS estimates in 5 of its last 5 evaluated quarters (beat rate: 100%).
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
Basis: price reactions to the last 4 report dates (close to close).
Basis: 5 quarters with an analyst estimate and reported EPS.
Past price reactions are not a reliable indicator of future performance.